Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

331
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
331
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

499
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
499
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

326
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
326
Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Urinary Bladder01:23

Urinary Bladder

2.9K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
2.9K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Wide Spectrum of Oncocytic Changes and Tumors in the Kidney: Splitting and Lumping.

Pathobiology : journal of immunopathology, molecular and cellular biology·2021
Same author

Molecular pathology of urothelial carcinoma.

Human pathology·2021
Same author

Digital diagnostics and artificial intelligence in prostate cancer treatment in 5 years from now.

Translational andrology and urology·2021
Same author

Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review.

Translational andrology and urology·2021
Same author

Narrative review: update on immunotherapy and pathological features in patients with bladder cancer.

Translational andrology and urology·2021
Same author

Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?

Translational andrology and urology·2021

Related Experiment Video

Updated: Jan 2, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

5.3K

Bladder cancer: clinical and pathological profile.

Antonio Lopez-Beltran1

  • 1Unit of Anatomic Pathology, Department of Surgery, Faculty of Medicine, Avenida Menendez-Pidal s/n, Cordoba University Medical School, Cordoba, Spain. em1lobea@uco.es

Scandinavian Journal of Urology and Nephrology. Supplementum
|December 5, 2008
PubMed
Summary

Bladder tumors are diverse, often recurring and progressing. This review covers their classification, clinical presentation, and management, emphasizing the 2004 World Health Organization (WHO) system for urothelial carcinoma.

More Related Videos

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
06:12

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

7.6K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.0K

Related Experiment Videos

Last Updated: Jan 2, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

5.3K
Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
06:12

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

7.6K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.0K

Area of Science:

  • Urology
  • Oncology
  • Pathology

Background:

  • Bladder tumors exhibit heterogeneous behavior, characterized by recurrence and progression.
  • Recurrence and progression rates are influenced by tumor grade and stage.
  • The World Health Organization (WHO) classification system aids in defining bladder tumor categories.

Purpose of the Study:

  • To summarize recent literature on bladder urothelial carcinoma pathology and clinical management.
  • To highlight the significance of clinical presentation, tumor characteristics, and classification systems.
  • To discuss the clinical utility of the 2004 WHO classification, particularly for papillary urothelial neoplasia of low malignant potential (PUNLMP).

Main Methods:

  • Literature review of recent publications on bladder urothelial carcinoma.
  • Analysis of clinical presentation, macroscopic appearance, and tumor characteristics.
  • Evaluation of the 2004 WHO classification system for bladder tumors.

Main Results:

  • The 2004 WHO classification provides improved definition of bladder tumor categories.
  • PUNLMP demonstrates lower malignant potential compared to low-grade carcinoma.
  • Clinical presentation, including hematuria and tumor morphology, is crucial for management.

Conclusions:

  • Accurate classification of bladder tumors is essential for predicting recurrence and progression.
  • The clinical utility of the PUNLMP category requires further discussion and potential re-evaluation.
  • Effective management of bladder urothelial carcinoma relies on integrating pathological findings with clinical presentation.